FRA:EIIA (Japan)
Â
ADR (Unsponsored)
€
6.35
-0.050 (-0.78%)
Mar 21
What is a stock summary page? Click here for an overview.
Business Description
Eisai Co Ltd
ISIN : US28258A1079
Share Class Description:
FRA:EIIA: ADR (Unsponsored)Compare
Compare
Traded in other countries / regions
4523.JapanESAIY.USAEII.Germany4523.Mexico IPO Date
2023-03-21Description
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.33 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.25 | |||||
| Debt-to-EBITDA | 1.79 | |||||
| Interest Coverage | 21.77 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.91 | |||||
| Beneish M-Score | -2.17 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -34 | |||||
| 3-Year EBITDA Growth Rate | -33.8 | |||||
| 3-Year EPS without NRI Growth Rate | -36.8 | |||||
| 3-Year FCF Growth Rate | -39.8 | |||||
| 3-Year Book Growth Rate | 7.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 12.71 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 4.74 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.65 | |||||
| 9-Day RSI | 50.01 | |||||
| 14-Day RSI | 47.83 | |||||
| 3-1 Month Momentum % | 4.03 | |||||
| 6-1 Month Momentum % | -36.14 | |||||
| 12-1 Month Momentum % | -30.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.99 | |||||
| Quick Ratio | 1.45 | |||||
| Cash Ratio | 0.77 | |||||
| Days Inventory | 408.79 | |||||
| Days Sales Outstanding | 96.16 | |||||
| Days Payable | 143.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.81 | |||||
| Dividend Payout Ratio | 0.74 | |||||
| Forward Dividend Yield % | 3.89 | |||||
| 5-Year Yield-on-Cost % | 3.98 | |||||
| Shareholder Yield % | 2.36 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 79.25 | |||||
| Operating Margin % | 9 | |||||
| Net Margin % | 7.43 | |||||
| FCF Margin % | 0.3 | |||||
| ROE % | 6.94 | |||||
| ROA % | 4.31 | |||||
| ROIC % | 5.4 | |||||
| 3-Year ROIIC % | -1.45 | |||||
| ROC (Joel Greenblatt) % | 25.67 | |||||
| ROCE % | 7.92 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 20.53 | |||||
| Forward PE Ratio | 21.82 | |||||
| PE Ratio without NRI | 20.53 | |||||
| Shiller PE Ratio | 5.83 | |||||
| Price-to-Owner-Earnings | 384.78 | |||||
| PS Ratio | 1.53 | |||||
| PB Ratio | 1.37 | |||||
| Price-to-Tangible-Book | 2.23 | |||||
| Price-to-Free-Cash-Flow | 751.84 | |||||
| Price-to-Operating-Cash-Flow | 64.32 | |||||
| EV-to-EBIT | 14.26 | |||||
| EV-to-Forward-EBIT | 28.16 | |||||
| EV-to-EBITDA | 9.6 | |||||
| EV-to-Forward-EBITDA | 17.72 | |||||
| EV-to-Revenue | 1.48 | |||||
| EV-to-Forward-Revenue | 2.7 | |||||
| EV-to-FCF | 691.65 | |||||
| Price-to-GF-Value | 0.66 | |||||
| Price-to-Projected-FCF | 1.25 | |||||
| Price-to-Median-PS-Value | 1.61 | |||||
| Price-to-Graham-Number | 1.44 | |||||
| Price-to-Net-Current-Asset-Value | 6.05 | |||||
| Earnings Yield (Greenblatt) % | 7.01 | |||||
| FCF Yield % | 0.14 | |||||
| Forward Rate of Return (Yacktman) % | -25.16 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Eisai Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 4,859.488 | ||
| EPS (TTM) (€) | 0.317 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 46.36 | ||
| 14-Day RSI | 47.83 | ||
| 14-Day ATR (€) | 0.090439 | ||
| 20-Day SMA (€) | 6.37 | ||
| 12-1 Month Momentum % | -30.27 | ||
| 52-Week Range (€) | 6 - 10.5 | ||
| Shares Outstanding (Mil) | 1,127.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eisai Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eisai Co Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Eisai Co Ltd Frequently Asked Questions
What is Eisai Co Ltd(FRA:EIIA)'s stock price today?
The current price of FRA:EIIA is €6.35. The 52 week high of FRA:EIIA is €10.50 and 52 week low is €6.00.
When is next earnings date of Eisai Co Ltd(FRA:EIIA)?
The next earnings date of Eisai Co Ltd(FRA:EIIA) is .
Does Eisai Co Ltd(FRA:EIIA) pay dividends? If so, how much?
The Dividend Yield %  of Eisai Co Ltd(FRA:EIIA) is 3.81% (As of Today), Highest Dividend Payout Ratio of Eisai Co Ltd(FRA:EIIA) was 1.08. The lowest was 0.09. And the median was 0.26. The  Forward Dividend Yield % of Eisai Co Ltd(FRA:EIIA) is 3.89%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers